mRNA |
THZ-2-49 |
GDSC1000 |
pan-cancer |
AAC |
0.063 |
0.07 |
mRNA |
BRD-K11533227 |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.07 |
mRNA |
Merck60 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.07 |
mRNA |
MPS-1-IN-1 |
GDSC1000 |
pan-cancer |
AAC |
0.067 |
0.07 |
mRNA |
TL-2-105 |
GDSC1000 |
pan-cancer |
AAC |
-0.068 |
0.07 |
mRNA |
BRD-K17060750 |
CTRPv2 |
pan-cancer |
AAC |
0.079 |
0.08 |
mRNA |
navitoclax:gemcitabine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.07 |
0.08 |
mRNA |
Epothilone B |
GDSC1000 |
pan-cancer |
AAC |
0.072 |
0.08 |
mRNA |
Nilotinib |
GDSC1000 |
pan-cancer |
AAC |
-0.078 |
0.08 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.071 |
0.08 |